April 2008 
 Chiropractic Cardiovascular Update
March 2008 SOT Research Update
SOTO-USA's Multidisciplinary Annual Event
SOT Related Research Information
Research Conferences
Research Search Engines
SOT Research Literature
SOT and Chiropractic Research Lists
International SOT Events
Chiropractic Peer Review Journals
The Alliance of TMD Organizations
Getting the Word Out About SOT
SOT and SOT Cranial Events





Join our mailing list!

Dear Colleague:

The Research Updates are a service offered by SOTO-USA to keep doctors who are familiar with sacro occipital technique (SOT) aware of the latest research related events, papers, and concepts affecting our practices. Please contact me directly at drcblum@aol.com if you are aware of others who might be interested in receiving this quarterly newsletter.

Please don't miss SOTO-USA's 9th Annual CLINICAL SYMPOSIUM, October 23-26th, 2008, in Dallas, Texas.

SOT and SOT cranial seminar series are now taking place in California. See this newsletter for more information. Also there are SOT and SOT cranial pediatric classes being held throughout the United States held through the ICPA.

Don't forget your can always have SOTO-USA come to you by: Designing Your Own SOT Seminar - Click Here for Information

This update features information on some relatively new concepts on cardiovascular health and cholesterol which may be of importance for the chiropractic profession.

 

SOT and SOT Cranial Regional Series


 

2008 Marks the beginning of SOT and SOT cranial series taking place in Southern California. The Southern California University of Health Sciences - Los Angeles Chiropractic College (SCU) is offering a series of SOT seminar.

SCU will be featuring on campus (in the Los Angeles, CA area) a two year SOT and SOT cranial program supplying all doctors and students the courses they need to sit for the SOT certification examinations. All the SOT and SOT Cranial series will be held on campus at SCU and presented quarterly.

SOT Level One - June 7-8, 2008 will be taught by Drs. Charles Blum and Richard Gerardo.

SOT Level Two will be held in September 2008 on campus at SCU at a date to be determined shortly.

For registration and information please click here.



SOT Pediatric seminars can be found all over the USA.

April 5-6th SOT Spinal at Overland Park, Kansas,

April 19-20th SOT Cranial at Dallas, TX,

June 14-15th SOT Spinal at Atlanta, GA.

For future dates visit the ICPA website, for SOT Spinal click here and SOT Cranial click here.



SOT Events Calendar 


 

Cholesterol, Chiropractic and Cardiovascular Health


 

Chiropractors are developing an interest in cholesterol levels, medications, and vascular issues since in the past there have been implications of a relationship between cervical manipulations and cerebrovascular arterial (CVA) events [1]. Apparently current research has found that the purported relationship to be so rare that any factors associated with chiropractic manipulation and CVA events are more coincidental than causal [2-4]. Therefore the chiropractic profession has been focusing on how to be aware of a CVA event in progress and how to prevent such an occurrence, leads to the need to understand the importance of the current relationship between cholesterol levels and vascular events.

In one study that analyzed 61 prospective observational studies they failed to find any association of total cholesterol (TC) with stroke mortality. Ultimately the total cholesterol (TC)/HDL cholesterol ratio was found to be more predictive of ischemic heart disease (IHD) mortality than total or non-HDL cholesterol. They also found a positive relation between cholesterol and stroke only in middle age and only in those with below-average blood pressure (BP); at older ages (70-89), and particularly for those with systolic BP greater than 145 mm Hg, total cholesterol was negatively related to hemorrhagic and total stroke mortality [5,6].

In the Ezetimibe (Zetia) and Simvastatin (Zocor) in Hypercholesterolemia Enhances Atherosclerosis Regression (ENHANCE) study they found in their trial that patients who had an LDL cholesterol level of 178 mg per deciliter (4.60 mmol per liter) while receiving combination therapy with simvastatin plus ezetimibe, the carotid intima-media thickness progressed by 0.0111 mm. With a similar level of LDL cholesterol (167 mg per deciliter [4.32 mmol per liter]) during therapy with 80 mg of atorvastatin (Lipitor) in the ASAP study, intima-media thickness regressed substantially, by 0.031 mm 7.

However it has been questioned, "Does the ENHANCE study prove that ezetimibe provides no benefit when added to statin therapy or, for that matter, as monotherapy? For now, the study's findings are a red flag but not a black box [8]."

"The results of ongoing trials, such as the Improved Reduction of Outcomes: Vytorin Efficacy International Trial [IMPROVE-IT]), which will not be available until at least 2011, are expected not only to help define the role of ezetimibe in the treatment of hypercholesterolemia but also to provide insight into the biology of LDL cholesterol lowering and the use of carotid intima-media thickness as a surrogate indicator of coronary events [9].

"Until such data are available, it seems prudent to encourage patients whose LDL cholesterol levels remain elevated despite treatment with an optimal dose of a statin to redouble their efforts at dietary control and regular exercise. Niacin, fibrates, and resins should be considered when diet, exercise, and a statin have failed to achieve the target, with ezetimibe reserved for patients who cannot tolerate these agents [9]."

The direction of vascular health and prevention seems to be towards issues of vascular inflammation and TC/HDL ratios 6 and not so much on lowering total cholesterol levels. Therefore some markers such as homocysteine [10-12], c-reactive protein [13,14] and clinical indicators of precursors of vascular inflammatory processes [15] may offer a window into a patient's potential cardiovascular health. There is even some suggestion that the positive affects of statin medications are associated with their ability to reduce vascular inflammation processes [16] and not related to their affect on cholesterol. So far that leaves us best with interventions that offer low risk such as exercise [17,18], low inflammatory diets [19], and increasing omega three supplementation [20] all of which would seem to be the recommended first line in treatment and prevention of possible vascular events.

1. Haneline MT, Rosner AL. The etiology of cervical artery dissection. Journal of Chiropractic Medicine. Sep 2007; 6(3): 110-120.

2. Thiel HW, Bolton JE, Docherty S, Portlock JC. Safety of Chiropractic Manipulation of the Cervical Spine: A Prospective National Survey. Spine. 32(21):2375-2378, October 1, 2007.

3. Rubinstein SM, Leboeuf-Yde C, Knol DL, de Koekkoek TE, Pfeifle CE, van Tulder MW. The Benefits Outweigh the Risks for Patients Undergoing Chiropractic Care for Neck Pain: A Prospective, Multicenter, Cohort Study. J Manip Physiological Therapeutics. Jul 2007;30(6): 408-18.

4. Cassidy JD, Boyle E, Côté P, He Y, Hogg- Johnson S, Silver FL, Bondy SJ. Risk of vertebrobasilar stroke and chiropractic care: results of a population-based case-control and case-crossover study. Spine. 2008 Feb 15;33(4 Suppl):S176-83.

5. Prospective Studies Collaboration. Blood cholesterol and vascular mortality by age, sex and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55 000 vascular deaths. Lancet. 2007;370:1829-1839.

6. Amarenco P, Steg PG. The paradox of cholesterol and stroke. Lancet. 2007;370:1803- 1804.

7. Kastelein JJ, Akdim F, Stroes ES, Zwinderman AH, Bots ML, Stalenhoef AF, Visseren FL, Sijbrands EJ, Trip MD, Stein EA, Gaudet D, Duivenvoorden R, Veltri EP, Marais AD, de Groot E; the ENHANCE Investigators..Simvastatin with or without Ezetimibe in Familial Hypercholesterolemia. N Engl J Med 2008;358:1431-a-1443.

8. Brown BG, Taylor AJ. Does ENHANCE Diminish Confidence in Lowering LDL or in Ezetimibe? N Engl J Med. 2008 Mar 30.

9. Drazen JM, Jarcho JA, Morrissey S, Curfman GD, Cholesterol Lowering and Ezetimibe. N Engl J Med; March 30, 2008.

10. Cui R, Moriyama Y, Koike KA, Date C, Kikuchi S, Tamakoshi A, Iso H; JACC Study group. Serum total homocysteine concentrations and risk of mortality from stroke and coronary heart disease in Japanese: The JACC study. Atherosclerosis. 2007 Dec 27;

11. Vanuzzo D, Pilotto L, Lombardi R, Lazzerini G, Carluccio M, Diviacco S, Quadrifoglio F, Danek G, Gregori D, Fioretti P, Cattaneo M, De Caterina R. Both vitamin B6 and total homocysteine plasma levels predict long-term atherothrombotic events in healthy subjects. Eur Heart J. 2007 Feb;28(4):484-91.

12. Tanne D, Haim M, Goldbourt U, Boyko V, Doolman R, Adler Y, Brunner D, Behar S, Sela BA.. Prospective study of serum homocysteine and risk of ischemic stroke among patients with preexisting coronary heart disease. Stroke. 2003 Mar;34(3):632- 6.

13. Tanne D, Benderly M, Goldbourt U, Haim M, Tenenbaum A, Fisman EZ, Matas Z, Adler Y, Zimmlichman R, Behar S, C- Reactive Protein as a Predictor of Incident Ischemic Stroke Among Patients With Preexisting. Cardiovascular Disease. Stroke. 2006 Jul;37(7):1720-4.

14. Cao JJ, Thach C, Manolio TA, Psaty BM, Kuller LH, Chaves PH, Polak JF, Sutton-Tyrrell K, Herrington DM, Price TR, Cushman M. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation. 2003 Jul 15;108(2):166-70.

15. O'Callaghan PA, Fitzgerald A, Fogarty J, Gaffney P, Hanbidge M, Boran G, Enright H, Murphy J, McCarthy B, Graham IM. New and old cardiovascular risk factors: C-reactive protein, homocysteine, cysteine and von Willebrand factor increase risk, especially in smokers. Eur J Cardiovasc Prev Rehabil. 2005 Dec;12(6):542-7.

16. Shishehbor MH, Brennan ML, Aviles RJ, Fu X, Penn MS, Sprecher DL, Hazen SL. Statins promote potent systemic antioxidant effects through specific inflammatory pathways.Circulation. 2003 Jul 29;108(4):426-31.

17. Kodama S, Tanaka S, Saito K, Shu M, Sone Y, Onitake F, Suzuki E, Shimano H, Yamamoto S, Kondo K, Ohashi Y, Yamada N, Sone H. Effect of aerobic exercise training on serum levels of high- density lipoprotein cholesterol: a meta-analysis. Arch Intern Med. 2007 May 28;167(10):999-1008.

18. Halverstadt A, Phares DA, Wilund KR, Goldberg AP, Hagberg JM. Endurance exercise training raises high-density lipoprotein cholesterol and lowers small low-density lipoprotein and very low- density lipoprotein independent of body fat phenotypes in older men and women. Metabolism. 2007 Apr;56(4):444-50.

19. Seaman DR. The Diet-Induced Proinflammatory State: A Cause of Chronic Pain and Other Degenerative Diseases? J Manipulative Physiol Ther 2002; 25:168-79.

20. Calabresi L, Villa B, Canavesi M, Sirtori CR, James RW, Bernini F, Franceschini G. An omega-3 polyunsaturated fatty acid concentrate increases plasma high-density lipoprotein 2 cholesterol and paraoxonase levels in patients with familial combined hyperlipidemia. Metabolism. 2004 Feb;53(2):153- 8.

 


Sacro Occipital Technique Organization - USA is a non-profit, professional organization formed to promote the awareness, understanding and utilization of the Sacro Occipital Technique method of chiropractic as founded and developed by Dr. Major Bertrand DeJarnette.

The SOTO-USA family all looks forward to seeing you October 23-26th, for the 2008 National Clinical Symposium in Dallas, Texas. It will be a great opportunity learn the essence of SOT or advance your SOT training with integrative classes in SOT, CMRT, and Cranial. For those interested in working with the dental profession treating TMD then this symposium will be leading the way.

We respect your privacy, and if you believe that you have received this email in error, or would like to be removed from our mailing list for any reason, to protect yourself, please click on the link below that says, "Instant removal with SafeUnsubscribe."

Thank you for your dedication and interest


Charles Blum, DC
Sacro Occipital Technique Organization - USA

phone: 336-793-6524
fax: 336-372-1541